Histoplasma Antigen Quantitative by EIA, Serum

0092522
copy
 

Copy Utility


emailprint
Example Reports
Detected
Negative
Not Detected
Positive
COMPONENT DESCRIPTION TEST TYPE INFECTIOUS UNIT OF MEASURE NUMERIC MAP LOINC
0092523
Histoplasma Antigen, Serum Interp
Resultable
N
44525-4
0060749
Histoplasma Antigen, Serum
Resultable
N
ng/mL
XX.XX
6428-7

For questions regarding the Interface Map, please contact interface.support@aruplab.com.


Download to Excel
Ordering Recommendation

Aid in the diagnosis of histoplasmosis. Recommend testing in conjunction with Histoplasma Antibodies by CF & ID (0050627) and Histoplasma Galactomannan Antigen Quantitative by EIA, Urine (2009418).

Mnemonic
HISTOAG S
Methodology

Quantitative Enzyme Immunoassay

Performed

Mon, Wed, Fri

Reported

1-4 days

New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Collect

Plain Red or Serum Separator Tube (SST).

Specimen Preparation

Transfer 2 mL serum to a sterile ARUP Standard Transport Tube (ARUP Supply #43115). (Min: 1 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Specimen types other than those listed.

Remarks
Stability

Ambient: Unacceptable; Refrigerated: 2 weeks; Frozen: 1 month (avoid repeated freeze/thaw cycles)

Reference Interval

Not Detected

Interpretive Data

The quantitative range of this assay is 0.19-60.0 ng/mL. Antigen concentrations less than 0.19ng/mL or  greater than 60.0 ng/mL fall outside the linear range of the assay and cannot be accurately quantified.

This EIA test should be used in conjunction with other diagnostic procedures, including microbiological culture, histological examination of biopsy samples, serology and/or radiographic evidence, to aid in the diagnosis of histoplasmosis.

Crossreactivity with Blastomyces dermatiditis, Coccidioides immitis, and possibly Talaromyces marneffei have been observed with this EIA. Other clinically and geographically relevant endemic mycoses should be considered in the case of a positive test result.

Test developed and characteristics determined by ARUP Laboratories. See Compliance Statement B: aruplab.com/CS

Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note

For urine, refer to test Histoplasma Galactomannan Antigen Quantitative by EIA, Urine (ARUP test code 2009418).

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
11/18/2019
X
X
08/19/2019
X
X
X
X
X
X
X
X
N/A
CPT Codes

87385

Are you an ARUP Client? Click here for your pricing.
Components
Component Test Code* Component Chart Name LOINC
0060749 Histoplasma Antigen, Serum 6428-7
0092523 Histoplasma Antigen, Serum Interp 44525-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Histoplasma antigen immunoassay
  • serum histoplasma
Histoplasma Antigen Quantitative by EIA, Serum